Cargando…
New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19
Nowadays, coronavirus disease 2019 (COVID-19) represents the most serious inflammatory respiratory disease worldwide. Despite many proposed therapies, no effective medication has yet been approved. Neutrophils appear to be the key mediator for COVID-19-associated inflammatory immunopathologic, throm...
Autores principales: | El Tabaa, Manar Mohammed, El Tabaa, Maram Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527794/ https://www.ncbi.nlm.nih.gov/pubmed/33011243 http://dx.doi.org/10.1016/j.ejphar.2020.173615 |
Ejemplares similares
-
Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost
por: Mohammed El Tabaa, Manar, et al.
Publicado: (2020) -
Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057]
por: Mohammed El Tabaa, Manar, et al.
Publicado: (2020) -
Silymarin constrains diacetyl-prompted oxidative stress and neuroinflammation in rats: involvements of Dyn/GDNF and MAPK signaling pathway
por: Tabaa, Manar Mohammed El, et al.
Publicado: (2022) -
Does ( −)-epigallocatechin-3-gallate protect the neurotoxicity induced by bisphenol A in vivo?
por: El Tabaa, Manar Mohammed, et al.
Publicado: (2022) -
Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer’s Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2013)